IP Library › Assignment 062493/0011
Patent Assignment
Reel/Frame 062493/0011

Change of Name

Recorded: 2023-01-25 Pages: 2
Assignor
Assignee
BAUSCH HEALTH COMPANIES INC.
2150 BOUL. SAINT-ELZÉAR WEST, LAVAL, H7L 4A8, CANADA
Covered Property (1)
Formulations of Calcium and Phosphate for Oral Inflammation
Application: 14/945,865 →
Publication: US 2016/0175356
Related Assignments (19)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 19, 2015
From: INVADO PHARMACEUTICALS LLC
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 037089/0440 →
Assignment of Assignor's Interest Nov 19, 2015
From: WELDON, BARTHOLOMEW; KOBUS, EDWARD; DUMOULIN, SANDRYNE; BETANCOURT, AIMESTHER
To: INVADO PHARMACEUTICALS LLC
Reel/Frame 037089/0309 →
Security Interest Jul 19, 2017
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043045/0959 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Intellectual Property Security Agreement Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Security Interest Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Agreement (First Lien) Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien) Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (First Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Security Agreement (Second Lien) Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
Security Interest Feb 13, 2023
From: BAUSCH HEALTH COMPANIES INC.; VALEANT CANADA LP; VALEANT CANADA GP LIMITED; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 062670/0260 →
Security Interest Mar 15, 2023
From: BAUSCH HEALTH COMPANIES INC.; VALEANT CANADA LP; VALEANT CANADA GP LIMITED; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 062983/0494 →
Release of Security Interest Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.
Reel/Frame 070778/0199 →
Release of Security Interest Apr 14, 2025
From: BARCLAYS BANK PLC
To: BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH COMPANIES INC.
Reel/Frame 070830/0577 →
U.S. Patent Security Agreement Jun 13, 2025
From: BAUSCH HEALTH COMPANIES INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 071566/0272 →
Canadian Intellectual Property Security Agreement Jun 13, 2025
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; 1261229 B.C. LTD.; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 071566/0056 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
Reel/Frame 073637/0001 →
Release of Security Interest Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 073637/0222 →